An interventional study of Standard of Care Physical Therapy and Blood flow restriction in Achilles Injuries Tendon, sponsored by NYU Langone Health. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-06-08.
Sponsored by NYU Langone Health · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Tendon Injuries with a site in United States — 4 open to participants now, 7 under way, none of them phase 3. Tendon Injuries · United States.
Among the 23 studies in Tendon Injuries with a site in United States, this one is the 6th largest by planned enrollment of the 18 interventional ones that give a count, is the only one that started in 2021, is one of 13 with no phase, and was the 15th registered.
101 studies on the registry are indexed under Tendon Injuries; 28 are open to participants now.
Browse Tendon Injuries studies →4 of the 23 studies in Tendon Injuries with a site in United States are open now. Recruiting first, the newest first:
Rocky Vista University, LLC · Sites in United States
Ages 18–40 · Healthy volunteers
Research Source · Sites in United States
Ages 18–90 · Healthy volunteers
Spaulding Rehabilitation Hospital · Sites in United States
Ages 18–65
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 12 Tendon Injuries studies recruiting now, 5 (42%) set no upper age limit and 7 (58%) stop at 75 or younger; 3 take children under 18; 2 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 1 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 57 is above the median of 44 across 71 interventional studies indexed under Tendon Injuries.
Median enrollment 28 across the 18 interventional studies, 100 across the 5 observational. Of the 13 that completed or were terminated, 3 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 23 have an industry lead sponsor. The 10 most frequent:
NYU Langone Health is the lead sponsor of 1,431 studies on the registry; 258 are open to participants now.
Of its 235 completed or terminated interventional studies of FDA-regulated products, 197 (84%) have results posted.
NYU Langone Health has 1 study filed under Tendon Injuries — fewer than ten, so there is no comparison to draw.
2 of the studies in Tendon Injuries with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05735119Zimmer BiometEmbody Post-Market Clinical Follow-Up Study | 2026-11 |
| NCT07498166Massachusetts General HospitalProject Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 23 studies in Tendon Injuries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Blood flow restriction (BFR) therapy is a brief and partial restriction of venous outflow of an extremity during low load resistance exercises. It is a safe and effective method of improving strength in healthy and active individuals, recovering from orthopedic pathologies and procedures. This prospective, randomized study will look at the implications this form of treatment has on the rehabilitation of Achilles injuries.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with Achilles injury are prescribed PT for their treatment, therefore physical therapy is a standard of care treatment for patients with tendon pathology.
Other: Standard of Care Physical Therapy
Blood flow restriction therapy is a blood pressure cuff placed around the desired limb with a handheld device that controls the pressure exerted by the cuff.
Other: Blood flow restriction
Will receive standard of care physical therapy
Blood flow restriction therapy is a blood pressure cuff placed around the desired limb with a handheld device that controls the pressure exerted by the cuff. The cuff is placed around the desired limb before a specific exercise, the physical therapist determines the appropriate pressure and time, and the patient completes the exercise as they normally would. The monitor determines the limb occlusion pressure and has an automatic timer that will deflate after the specified time has elapsed.
efficacy of blood flow restriction therapy on patients with Achilles injury by measure pre and post blood flow restriction therapy measured by muscle strength
Measure in increase of strength in the affected leg measured by Biodex.
Time frame: 12 Months
Measure of pain using Visual Analog Scale (VAS)
Respondent selects a whole number (0-10 integers) that best reflects the intensity of their pain. For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 \[100-mm scale\])
Time frame: 12 Months
Plan to share: Yes — Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
Supporting information: Study protocol, Statistical analysis plan
Time frame: Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access criteria: Requests should be directed to David.Bloom@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
No publications or documents are linked to this record.
Started Oct 2021 (actual). Primary completion is estimated for Jun 2026, 55 months after the start.
Of 37 non-industry interventional studies with no phase under Tendon Injuries, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 46. This study's planned 55 months is above that.
Counting every sponsor, half of 39 studies reached it within 14 months; a quarter within 7 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.